These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26018883)

  • 1. Pulmonary emphysema induced by methylphenidate: experimental study.
    Rapello GV; Antoniolli A; Pereira DM; Facco G; Pêgo-Fernandes PM; Pazetti R
    Sao Paulo Med J; 2015; 133(2):131-4. PubMed ID: 26018883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
    McGough JJ; McBurnett K; Bukstein O; Wilens TE; Greenhill L; Lerner M; Stein M
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):351-6. PubMed ID: 16768642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate-Induced Raynaud Phenomenon Developed After Increasing Methylphenidate in an Adult With Attention-Deficit Hyperactivity Disorder.
    Monteerarat Y; Pariwatcharakul P
    J Clin Psychopharmacol; 2019; 39(2):178-179. PubMed ID: 30811376
    [No Abstract]   [Full Text] [Related]  

  • 4. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
    Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
    CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.
    Baskin BM; Dwoskin LP; Kantak KM
    Pharmacol Biochem Behav; 2015 Apr; 131():51-6. PubMed ID: 25643872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.
    Holmskov M; Storebø OJ; Moreira-Maia CR; Ramstad E; Magnusson FL; Krogh HB; Groth C; Gillies D; Zwi M; Skoog M; Gluud C; Simonsen E
    PLoS One; 2017; 12(6):e0178187. PubMed ID: 28617801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms as a side effect of the sustained release form of methylphenidate in a 7-year-old boy with attention-deficit hyperactivity disorder.
    Lakić A
    Vojnosanit Pregl; 2012 Feb; 69(2):201-4. PubMed ID: 22500377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
    Childress AC; Kollins SH; Cutler AJ; Marraffino A; Sikes CR
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):66-74. PubMed ID: 27183299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There an Effect of Methylphenidate on Thrombocytopenia?
    Ercan ES; Inci SB; Ipci M
    J Clin Psychopharmacol; 2017 Jun; 37(3):374. PubMed ID: 28301399
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylphenidate-induced erections in a prepubertal child.
    Kelly BD; Lundon DJ; McGuinness D; Brady CM
    J Pediatr Urol; 2013 Feb; 9(1):e1-2. PubMed ID: 22552161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
    Wigal SB; Childress A; Berry SA; Belden H; Walters F; Chappell P; Sherman N; Orazem J; Palumbo D
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):690-699. PubMed ID: 28557548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse and toxicity of methylphenidate.
    Klein-Schwartz W
    Curr Opin Pediatr; 2002 Apr; 14(2):219-23. PubMed ID: 11981294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical leukoderma after the application of a transdermal methylphenidate patch.
    Ghasri P; Gattu S; Saedi N; Ganesan AK
    J Am Acad Dermatol; 2012 Jun; 66(6):e237-8. PubMed ID: 22583724
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.
    Silva RR
    Drugs; 2006; 66(8):1127-8; discussion 1128. PubMed ID: 16789798
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily methylphenidate use slows the growth of children: a community based study.
    Lisska MC; Rivkees SA
    J Pediatr Endocrinol Metab; 2003 Jun; 16(5):711-8. PubMed ID: 12880120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
    Inglis SK; Carucci S; Garas P; Häge A; Banaschewski T; Buitelaar JK; Dittmann RW; Falissard B; Hollis C; Kovshoff H; Liddle E; McCarthy S; Nagy P; Neubert A; Rosenthal E; Sonuga-Barke E; Wong I; Zuddas A; Coghill DC;
    BMJ Open; 2016 Apr; 6(4):e010433. PubMed ID: 27118284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate-Release Methylphenidate-Associated Recurrent Nasal Bleeding in Siblings.
    Chandradasa M; Rathnayake LC
    J Clin Psychopharmacol; 2019; 39(3):284-285. PubMed ID: 30932948
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.